At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SLXN Silexion Therapeutics Corp
Trading 01-29 15:19:24 EST
1.99
-0.05
-2.45%
High2.04
Low1.87
Vol47.77K
Open2.03
D1 Closing2.04
Amplitude8.33%
Mkt Cap6.22M
Tradable Cap5.48M
Total Shares3.13M
T/O92.47K
T/O Rate1.74%
Tradable Shares2.75M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit
Silexion Therapeutics Announces Groundbreaking Preclinical Results for SIL204, Demonstrating Near-Complete Inhibition of Pan-KRAS Mutations Across Multiple Cancer Types
Silexion Therapeutics Announces Positive New Human Cell Line Data Confirming Pan-Kras Activity of Sil204, Demonstrating up to 99.7% Inhibition and First Evidence in Gastric Cancer
Moringa Acquisition Corp does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company focuses on pursuing opportunities in technology-based businesses or industries in Israel. Moringa Acquisition Corp was incorporated in 2020 and is based in New York, New York.